Table 1:
Baseline characteristics of PAD patients included and excluded from cohort
| Variable | Included | Not included | p-value |
|---|---|---|---|
| N | 781 | 987 | |
| Symptom Severity | < .001 | ||
| Asymptomatic | 271 (34.7%) | 288 (29.2%) | |
| IC | 339 (43.4%) | 391 (39.6%) | |
| CLTI | 171 (21.9%) | 308 (31.2%) | |
| Demographics | |||
| Age (years), Mean (SD) | 72.51 (9.84) | 71.61 (9.71) | .02 |
| Age Category | .08 | ||
| < 65 | 144 (18.4%) | 204 (20.7%) | |
| 65 - < 75 | 293 (37.5%) | 408 (41.3%) | |
| 75 - < 85 | 257 (32.9%) | 282 (28.6%) | |
| ≥ 85 | 87 (11.1%) | 93 (9.4%) | |
| Sex, Male | 468 (59.9%) | 568 (57.5%) | .31 |
| Race (RTI) | < .001 | ||
| White | 522 (66.8%) | 606 (61.4%) | |
| Black | 235 (30.1%) | 296 (30.0%) | |
| Other/Unknown | 24 (3.1%) | 85 (8.6%) | |
| Medicaid Dual Enrollment | 149 (19.1%) | 273 (27.7%) | < .001 |
| Smoking History | .003 | ||
| Never | 145 (18.6%) | 180 (18.2%) | |
| Current | 120 (15.4%) | 213 (21.6%) | |
| Former | 516 (66.1%) | 594 (60.2%) | |
| Geographic-based | |||
| Non-metropolitan area (vs. metro) | 152 (19.5%) | 398 (40.3%) | < .001 |
| Household Income, Median $ (Q1, Q3) | 55,022 (41,184, 72,616) | 43,603 (32,407, 56,393) | < .001 |
| Medical History | |||
| Prior Statins, yes | 658 (84.3%) | 583 (59.1%) | < .001 |
| Comorbidities | |||
| Cancer | 146 (18.7%) | 176 (17.8%) | .64 |
| Cerebrovascular disease | 270 (34.6%) | 336 (34.0%) | .82 |
| Chronic obstructive pulmonary disease | 292 (37.4%) | 429 (43.5%) | .01 |
| Congestive heart failure | 232 (29.7%) | 287 (29.1%) | .77 |
| Dementia | 17 (2.2%) | 35 (3.5%) | .09 |
| Diabetes mellitus | 422 (54.0%) | 549 (55.6%) | .50 |
| Hypertension | 738 (94.5%) | 928 (94.0%) | .67 |
| Ischemic heart disease | 526 (67.3%) | 613 (62.1%) | .02 |
| Renal disease | 297 (38.0%) | 376 (38.1%) | .98 |
| Charlson score, Mean (SD) | 4.85 (2.97) | 4.95 (2.89) | .32 |
IC: intermittent claudication; CLTI: chronic limb-threatening ischemia;